247 related articles for article (PubMed ID: 34230557)
21. European epidemiological patterns of cannabis- and substance-related congenital cardiovascular anomalies: geospatiotemporal and causal inferential study.
Reece AS; Hulse GK
Environ Epigenet; 2022; 8(1):dvac015. PubMed ID: 35966825
[TBL] [Abstract][Full Text] [Related]
22. Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554603
[TBL] [Abstract][Full Text] [Related]
23. Congenital anomaly epidemiological correlates of Δ8THC across USA 2003-16: panel regression and causal inferential study.
Reece AS; Hulse GK
Environ Epigenet; 2022; 8(1):dvac012. PubMed ID: 35782486
[TBL] [Abstract][Full Text] [Related]
24. Clinical Epigenomic Explanation of the Epidemiology of Cannabinoid Genotoxicity Manifesting as Transgenerational Teratogenesis, Cancerogenesis and Aging Acceleration.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834053
[TBL] [Abstract][Full Text] [Related]
25. Patterns of Cannabis- and Substance-Related Congenital General Anomalies in Europe: A Geospatiotemporal and Causal Inferential Study.
Reece AS; Hulse GK
Pediatr Rep; 2023 Feb; 15(1):69-118. PubMed ID: 36810339
[TBL] [Abstract][Full Text] [Related]
26. Impact of converging sociocultural and substance-related trends on US autism rates: combined geospatiotemporal and causal inferential analysis.
Reece AS; Hulse GK
Eur Arch Psychiatry Clin Neurosci; 2023 Apr; 273(3):699-717. PubMed ID: 35779123
[TBL] [Abstract][Full Text] [Related]
27. Geospatiotemporal and causal inference study of cannabis and other drugs as risk factors for female breast cancer USA 2003-2017.
Reece AS; Hulse GK
Environ Epigenet; 2022; 8(1):dvac006. PubMed ID: 35386387
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoid and substance relationships of European congenital anomaly patterns: a space-time panel regression and causal inferential study.
Reece AS; Hulse GK
Environ Epigenet; 2022; 8(1):dvab015. PubMed ID: 35145760
[TBL] [Abstract][Full Text] [Related]
29. [SENTIERI: Epidemiological Study of Residents in National Priority Contaminated Sites. Fifth Report].
Zona A; Iavarone I; Buzzoni C; Conti S; Santoro M; Fazzo L; Pasetto R; Pirastu R; Bruno C; Ancona C; Bianchi F; Forastiere F; Manno V; Minelli G; Minerba A; Minichilli F; Stoppa G; Pierini A; Ricci P; Scondotto S; Bisceglia L; Cernigliaro A; Ranzi A; Comba P; ; ;
Epidemiol Prev; 2019; 43(2-3 Suppl 1):1-208. PubMed ID: 31295974
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of Δ8THC-Related Carcinogenesis in USA: A Panel Regression and Causal Inferential Study.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805384
[TBL] [Abstract][Full Text] [Related]
31. Childhood cancer risk in those with chromosomal and non-chromosomal congenital anomalies in Washington State: 1984-2013.
Norwood MS; Lupo PJ; Chow EJ; Scheurer ME; Plon SE; Danysh HE; Spector LG; Carozza SE; Doody DR; Mueller BA
PLoS One; 2017; 12(6):e0179006. PubMed ID: 28594943
[TBL] [Abstract][Full Text] [Related]
32. Cannabis- and Substance-Related Carcinogenesis in Europe: A Lagged Causal Inferential Panel Regression Study.
Reece AS; Bennett K; Hulse GK
J Xenobiot; 2023 Jul; 13(3):323-385. PubMed ID: 37489337
[TBL] [Abstract][Full Text] [Related]
33. Co-occurrence across time and space of drug- and cannabinoid- exposure and adverse mental health outcomes in the National Survey of Drug Use and Health: combined geotemporospatial and causal inference analysis.
Reece AS; Hulse GK
BMC Public Health; 2020 Nov; 20(1):1655. PubMed ID: 33148213
[TBL] [Abstract][Full Text] [Related]
34. Geospatiotemporal and Causal Inferential Study of European Epidemiological Patterns of Cannabis- and Substance-Related Congenital Orofacial Anomalies.
Reece AS; Hulse GK
J Xenobiot; 2023 Feb; 13(1):42-74. PubMed ID: 36810431
[TBL] [Abstract][Full Text] [Related]
35. The effect of cannabis toxicity on a model microbiome bacterium epitomized by a panel of bioluminescent E. coli.
Harpaz D; Veltman B; Sadeh Y; Marks RS; Bernstein N; Eltzov E
Chemosphere; 2021 Jan; 263():128241. PubMed ID: 33297188
[TBL] [Abstract][Full Text] [Related]
36. Environmental and individual exposure and the risk of congenital anomalies: a review of recent epidemiological evidence.
Baldacci S; Gorini F; Santoro M; Pierini A; Minichilli F; Bianchi F
Epidemiol Prev; 2018; 42(3-4 Suppl 1):1-34. PubMed ID: 30066535
[TBL] [Abstract][Full Text] [Related]
37. Using bayesian models to assess the effects of under-reporting of cannabis use on the association with birth defects, national birth defects prevention study, 1997-2005.
van Gelder MM; Donders AR; Devine O; Roeleveld N; Reefhuis J;
Paediatr Perinat Epidemiol; 2014 Sep; 28(5):424-33. PubMed ID: 25155701
[TBL] [Abstract][Full Text] [Related]
38. Canadian Cannabis Consumption and Patterns of Congenital Anomalies: An Ecological Geospatial Analysis.
Reece AS; Hulse GK
J Addict Med; 2020; 14(5):e195-e210. PubMed ID: 32187114
[TBL] [Abstract][Full Text] [Related]
39. Letter to the editor on "Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017, parts 1-3".
Chen FY; Barnes M; Lewis EC
Arch Public Health; 2022 Jul; 80(1):172. PubMed ID: 35850921
[TBL] [Abstract][Full Text] [Related]
40. Cancer risk in individuals with major birth defects: large Nordic population based case-control study among children, adolescents, and adults.
Daltveit DS; Klungsøyr K; Engeland A; Ekbom A; Gissler M; Glimelius I; Grotmol T; Madanat-Harjuoja L; Ording AG; Sæther SMM; Sørensen HT; Troisi R; Bjørge T
BMJ; 2020 Dec; 371():m4060. PubMed ID: 33268348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
